Emergence of Circulating Tumor DNA as a Precision Biomarker in Lung Cancer Radiation Oncology and Beyond [0.03%]
循环肿瘤DNA在肺癌放射治疗等领域的精准诊断中的应用初探
Ayesha Hashmi,Lilli J Greiner,Pradeep S Chauhan et al.
Ayesha Hashmi et al.
Circulating tumor DNA (ctDNA) is emerging as a transformative biomarker in the management of non-small cell lung cancer (NSCLC). This review focuses on its role in detecting minimal residual disease (MRD), predicting treatment response, and...
Erin McCammack,Sara Alcorn
Erin McCammack
Patient-reported outcomes (PROs) assessments arguably provide the most accurate description of the patient experience, as they are directly derived from the patient without the filter of a provider. Utilizing instruments to assess PROs in r...
Jessica Scarborough,Davis Weaver,Jacob Scott
Jessica Scarborough
Gene expression signatures (GES) are a powerful tool in oncology used for classification, prognostication, and therapeutic response prediction of malignancies. In this article, we review the disease site guidelines by the National Comprehen...
Xiaoying Liang,Homan Mohammadi,Kathryn C Moreno et al.
Xiaoying Liang et al.
Heavy ion radiotherapy is an emerging technology for treating radioresistant solid tumors. Unlike current low-linear energy transfer techniques, heavy ion radiotherapy, such as carbon ion radiotherapy, enhances the biologic effects related ...
Michael D&#x;Angelica
Michael D&#x;Angelica
Guillaume Martel,Kimberly A Bertens,Christina Canil
Guillaume Martel
Genitourinary cancers are common. Liver metastases from genitourinary cancers are uncommon; isolated liver metastasis is rare. Liver resection in select patients with metastatic renal cell carcinoma can lead to prolonged survival. Patients ...
Kiran H Clair,Juliet Wolford,Jason A Zell et al.
Kiran H Clair et al.
This article addresses the role of surgery in the management of gynecologic cancers with liver metastases. The authors review the short-term and long-term outcomes of aggressive resection through retrospective and randomized studies. Althou...
Brett L Ecker,Robert G Maki,Michael J Cavnar et al.
Brett L Ecker et al.
Sarcomas are rare mesenchymal tumors with a propensity for hematogenous metastasis. Gastrointestinal stromal tumor (GIST) is the most common histologic subtype and the most common source of hepatic metastases. In the case of metastatic GIST...
Catherine G Tran,Scott K Sherman,Chandrikha Chandrasekharan et al.
Catherine G Tran et al.
Patients with neuroendocrine tumor liver metastases (NETLMs) may develop carcinoid syndrome, carcinoid heart disease, or other symptoms from overproduction of hormones. Hepatic resection and cytoreduction is the most direct treatment of NET...
Amir A Rahnemai-Azar,Luke V Selby,Maryam B Lustberg et al.
Amir A Rahnemai-Azar et al.
Hepatic resection for patients with isolated breast cancer liver metastases (BCLM) is associated with prolonged disease-free interval and better overall survival in highly selected patients. Patients with limited disease who are not candida...